Showing results (1261-1270 of 1,277) with videos related to

Sort By:
Pageof 128
Nature Genetics|March 27, 2012
A genome-wide association study identifies three new risk loci for Kawasaki diseaseYoshihiro Onouchi, Kouichi Ozaki, Jane C Burns, et al.
Journal of the American College of Cardiology|December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart DiseaseR Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of GlioblastomaRachael A Vaubel, Shulan Tian, Dioval Remonde, et al.
The American Journal of Sports Medicine|October 6, 2021
A High-Sensitivity International Knee Documentation Committee Survey Index From the PROMIS System: The Next-Generation Patient-Reported Outcome for a Knee Injury PopulationMatthew S Tenan, Richard J Robins, Andrew J Sheean, et al.
Elife|October 27, 2022
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seqSara E Vazquez, Sabrina A Mann, Aaron Bodansky, et al.
Journal of Medicinal Chemistry|April 7, 2020
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of CancerJay B Fell, John P Fischer, Brian R Baer, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Med (New York, N.Y.)|August 19, 2023
Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signatureDominic Habgood-Coote, Clare Wilson, Chisato Shimizu, et al.
Nature Communications|May 27, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
Contemporary Clinical Trials|March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
Pageof 128